TWINLAB CONSOLIDATED HOLDINGS, INC. 8K

cbdMD, Inc. entered a definitive agreement to acquire Twinlab’s operating assets and brands via an ABC proceeding, materially expanding and diversifying its consumer wellness platform and revenue base, subject to court approval and closing conditions.

On September 2, 2026, cbdMD, Inc. announced that it entered into a definitive asset purchase agreement to acquire the operating assets and brands of Twinlab, including Twinlab, Reserveage, Metabolife, and Alvita Tea, through an assignment for the benefit of creditors proceeding, subject to court approval and customary closing conditions; the transaction is intended to provide stability for the Twinlab brands and their legacy obligations, diversify cbdMD’s business beyond hemp-derived products, and is expected, based on unaudited figures, to increase the combined company’s trailing twelve-month revenues ending June 2026 to approximately $30 million, about a 40% increase over cbdMD’s standalone revenue, with anticipated positive contribution after transaction and integration costs and a strategic shift toward a broader multi-brand consumer wellness platform.

Filing Facts

CIK

1590695

Ticker

-

Form

8K

Source Type

sec

Accession

0001753926-26-001687

Alert Tier

8